Anagrelide-Induced Supraventricular Tachycardia: A Case Report

Anagrelide is an inhibitor of the phosphodiesterase-3 (PDE-3) enzyme that suppresses megakaryocytes; hence it is used in the treatment of essential thrombocythemia. Anagrelide can cause positive inotropic and chronotropic effects on the cardiovascular system. Its cardiovascular side effects are rare...

Descripción completa

Detalles Bibliográficos
Autores principales: Badar, Faraz, Azeez, Hayder, Abdulrahman, Zeinab, Ashraf, Aqsa, Iftikhar, Asma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213328/
https://www.ncbi.nlm.nih.gov/pubmed/35747119
http://dx.doi.org/10.7759/cureus.26119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213328/
https://www.ncbi.nlm.nih.gov/pubmed/35747119
http://dx.doi.org/10.7759/cureus.26119

Ejemplares similares